Search Results - "Dhalluin, Christophe" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors

by Mahlangu, Johnny, Oldenburg, Johannes, Paz-Priel, Ido, Negrier, Claude, Niggli, Markus, Mancuso, M. Elisa, Schmitt, Christophe, Jiménez-Yuste, Victor, Kempton, Christine, Dhalluin, Christophe, Callaghan, Michael U, Bujan, Willem, Shima, Midori, Adamkewicz, Joanne I, Asikanius, Elina, Levy, Gallia G, Kruse-Jarres, Rebecca
Published in The New England journal of medicine (30.08.2018)

Get full text

Journal Article

Structure and ligand of a histone acetyltransferase bromodomain

Structure and ligand of a histone acetyltransferase bromodomain

by Zhou, Ming-Ming, Dhalluin, Christophe, Carlson, Justin E, Zeng, Lei, He, Cheng, Aggarwal, Aneel K, Zhou, Ming-Ming
Published in Nature (London) (03.06.1999)

Get full text

Journal Article

Structural and Biophysical Characterization of the 40 kDa PEG−Interferon-α2 a and Its Individual Positional Isomers

Structural and Biophysical Characterization of the 40 kDa PEG−Interferon-α2 a and Its Individual Positional Isomers

by Dhalluin, Christophe, Ross, Alfred, Leuthold, Luc-Alexis, Foser, Stefan, Gsell, Bernard, Müller, Francis, Senn, Hans
Published in Bioconjugate chemistry (18.05.2005)

Get full text

Journal Article

Structural, Kinetic, and Thermodynamic Analysis of the Binding of the 40 kDa PEG−Interferon-α2 a and Its Individual Positional Isomers to the Extracellular Domain of the Receptor IFNAR2

Structural, Kinetic, and Thermodynamic Analysis of the Binding of the 40 kDa PEG−Interferon-α2 a and Its Individual Positional Isomers to the Extracellular Domain of the Receptor IFNAR2

by Dhalluin, Christophe, Ross, Alfred, Huber, Walter, Gerber, Paul, Brugger, Doris, Gsell, Bernard, Senn, Hans
Published in Bioconjugate chemistry (18.05.2005)

Get full text

Journal Article

Magic Angle Spinning Nuclear Magnetic Resonance in Solid-Phase Peptide Synthesis

Magic Angle Spinning Nuclear Magnetic Resonance in Solid-Phase Peptide Synthesis

by Dhalluin, Christophe, Boutillon, Christophe, Tartar, André, Lippens, Guy
Published in Journal of the American Chemical Society (29.10.1997)

Get full text

Journal Article

A Model‐Based Framework to Inform the Dose Selection and Study Design of Emicizumab for Pediatric Patients With Hemophilia A

A Model‐Based Framework to Inform the Dose Selection and Study Design of Emicizumab for Pediatric Patients With Hemophilia A

by Yoneyama, Koichiro, Schmitt, Christophe, Chang, Tiffany, Dhalluin, Christophe, Nagami, Sayaka, Petry, Claire, Levy, Gallia G.
Published in Journal of clinical pharmacology (01.02.2022)

Get full text

Journal Article

Pharmacodynamic Biomarkers in Infants with Hemophilia A Receiving Emicizumab in HAVEN 7

Pharmacodynamic Biomarkers in Infants with Hemophilia A Receiving Emicizumab in HAVEN 7

by Kiialainen, Anna, Pipe, Steven, Fijnvandraat, Karin, Kenet, Gili, Schmitt, Christophe, Buri, Muriel, Jiménez-Yuste, Víctor, Oldenburg, Johannes, Mancuso, Maria Elisa, Dhalluin, Christophe, Lehle, Michaela, Collins, Peter
Published in Blood (02.11.2023)

Get full text

Journal Article

Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial

Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial

by Pipe, Steven W., Collins, Peter, Dhalluin, Christophe, Kenet, Gili, Schmitt, Christophe, Buri, Muriel, Jiménez-Yuste, Víctor, Peyvandi, Flora, Young, Guy, Oldenburg, Johannes, Mancuso, Maria Elisa, Kavakli, Kaan, Kiialainen, Anna, Deb, Sonia, Niggli, Markus, Chang, Tiffany, Lehle, Michaela, Fijnvandraat, Karin
Published in Blood (04.04.2024)

Get full text

Journal Article

Emicizumab Prophylaxis in Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Primary Analysis of the HAVEN 7 Study

Emicizumab Prophylaxis in Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Primary Analysis of the HAVEN 7 Study

by Pipe, Steven, Collins, Peter, Dhalluin, Christophe, Kenet, Gili, Schmitt, Christophe, Buri, Muriel, Jiménez-Yuste, Víctor, Peyvandi, Flora, Young, Guy, Oldenburg, Johannes, Mancuso, Maria Elisa, Kavakli, Kaan, Kiialainen, Anna, Chang, Tiffany, Lehle, Michaela, Niggli, Markus, Fijnvandraat, Karin
Published in Blood (02.11.2023)

Get full text

Journal Article

Emicizumab Prophylaxis for the Treatment of Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Interim Analysis of the HAVEN 7 Study

Emicizumab Prophylaxis for the Treatment of Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Interim Analysis of the HAVEN 7 Study

by Pipe, Steven W., Collins, Peter, Dhalluin, Christophe, Kenet, Gili, Schmitt, Christophe, Buri, Muriel, Jiménez-Yuste, Víctor, Peyvandi, Flora, Young, Guy, Oldenburg, Johannes, Mancuso, Maria Elisa, Kiialainen, Anna, Chang, Tiffany, Lehle, Michaela, Fijnvandraat, Karin
Published in Blood (15.11.2022)

Get full text

Journal Article

Factor VIII Use in the Treatment of Breakthrough Bleeds in Hemophilia A Patients without Inhibitors on Emicizumab Prophylaxis: The Phase 3 HAVEN 3 Study Experience

Factor VIII Use in the Treatment of Breakthrough Bleeds in Hemophilia A Patients without Inhibitors on Emicizumab Prophylaxis: The Phase 3 HAVEN 3 Study Experience

by Callaghan, Michael, Trzaskoma, Benjamin, Ko, Richard H., Lee, Lucy, Patel, Anisha M., Tzeng, Eunice, Shah, Michelle Lynn, Chang, Tiffany Y., Niggli, Markus, Dhalluin, Christophe, Mahlangu, Johnny
Published in Blood (13.11.2019)

Get full text

Journal Article

Solution Structure of ERK2 Binding Domain of MAPK Phosphatase MKP-3

Solution Structure of ERK2 Binding Domain of MAPK Phosphatase MKP-3

by Farooq, Amjad, Chaturvedi, Gaurav, Mujtaba, Shiraz, Plotnikova, Olga, Zeng, Lei, Dhalluin, Christophe, Ashton, Robert, Zhou, Ming-Ming
Published in Molecular cell (01.02.2001)

Get full text

Journal Article

HAVEN 2 Updated Analysis: Multicenter, Open-Label, Phase 3 Study to Evaluate Efficacy, Safety and Pharmacokinetics of Subcutaneous Administration of Emicizumab Prophylaxis in Pediatric Patients with Hemophilia A with Inhibitors

HAVEN 2 Updated Analysis: Multicenter, Open-Label, Phase 3 Study to Evaluate Efficacy, Safety and Pharmacokinetics of Subcutaneous Administration of Emicizumab Prophylaxis in Pediatric Patients with Hemophilia A with Inhibitors

by Young, Guy, Sidonio, Robert F., Liesner, Ri, Oldenburg, Johannes, Chang, Tiffany, Uguen, Marianne, Dhalluin, Christophe, Schmitt, Christophe, Levy, Gallia G., Shima, Midori, Mahlangu, Johnny
Published in Blood (08.12.2017)

Get full text

Journal Article

Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies

Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies

by Kruse-Jarres, Rebecca, Peyvandi, Flora, Oldenburg, Johannes, Chang, Tiffany, Chebon, Sammy, Doral, Michelle Y., Croteau, Stacy E., Lambert, Thierry, Kempton, Christine L., Pipe, Steven W., Ko, Richard H., Trzaskoma, Benjamin, Dhalluin, Christophe, Bienz, Nives Selak, Niggli, Markus, Lehle, Michaela, Paz-Priel, Ido, Young, Guy, Jiménez-Yuste, Víctor
Published in Blood advances (27.12.2022)

Get full text

Journal Article

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

by Kruse-Jarres, Rebecca, Callaghan, Michael U., Croteau, Stacy E., Jimenez-Yuste, Victor, Khoo, Liane, Liesner, Ri, Matsushita, Tadashi, Recht, Michael, Young, Guy, Chang, Tiffany, Dhalluin, Christophe, Mu, Yunming, Xu, Jin, Devenport, Jenny, Ko, Richard H., Solari, Paul, Oldenburg, Johannes
Published in Blood (08.12.2017)

Get full text

Journal Article

The BERNIE study: A phase II study evaluating addition of bevacizumab (Bv) to chemotherapy in children and adolescents with metastatic rhabdomyosarcoma (mRMS) and non-rhabdomyosarcoma soft tissue sarcoma (mNRSTS)

The BERNIE study: A phase II study evaluating addition of bevacizumab (Bv) to chemotherapy in children and adolescents with metastatic rhabdomyosarcoma (mRMS) and non-rhabdomyosarcoma soft tissue sarcoma (mNRSTS)

by Chisholm, Julia C., Casanova, Michela, Merks, Johannes H., Geoerger, Birgit, Rousseau, Raphael F., Moore, Nicola, Dhalluin, Christophe, Oberlin, Odile
Published in Journal of clinical oncology (20.05.2012)

Get full text

Journal Article

Solution Structure of ERK2 Binding Domain of MAPK Phosphatase MKP-3: Structural Insights into MKP-3 Activation by ERK2

Solution Structure of ERK2 Binding Domain of MAPK Phosphatase MKP-3: Structural Insights into MKP-3 Activation by ERK2

by Farooq, Amjad, Chaturvedi, Gaurav, Mujtaba, Shiraz, Plotnikova, Olga, Zeng, Lei, Dhalluin, Christophe, Ashton, Robert, Zhou, Ming-Ming
Published in Molecular cell (01.02.2001)

Get full text

Journal Article

Structural Basis of SNT PTB Domain Interactions with Distinct Neurotrophic Receptors

Structural Basis of SNT PTB Domain Interactions with Distinct Neurotrophic Receptors

by Dhalluin, Christophe, Yan, Kelley S, Plotnikova, Olga, Lee, Kyung W, Zeng, Lei, Kuti, Miklos, Mujtaba, Shiraz, Goldfarb, Mitchell P, Zhou, Ming-Ming
Published in Molecular cell (01.10.2000)

Get full text

Journal Article

Structural, Kinetic, and Thermodynamic Analysis of the Binding of the 40 kDa PEG−Interferon-α 2 a and Its Individual Positional Isomers to the Extracellular Domain of the Receptor IFNAR2

Structural, Kinetic, and Thermodynamic Analysis of the Binding of the 40 kDa PEG−Interferon-α 2 a and Its Individual Positional Isomers to the Extracellular Domain of the Receptor IFNAR2

by Dhalluin, Christophe, Ross, Alfred, Huber, Walter, Gerber, Paul, Brugger, Doris, Gsell, Bernard, Senn, Hans
Published in Bioconjugate chemistry (01.05.2005)

Get full text

Journal Article

Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers to the extracellular domain of the receptor IFNAR2

Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers to the extracellular domain of the receptor IFNAR2

by Dhalluin, Christophe, Ross, Alfred, Huber, Walter, Gerber, Paul, Brugger, Doris, Gsell, Bernard, Senn, Hans
Published in Bioconjugate chemistry (01.05.2005)

Get full text

Journal Article